Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases
暂无分享,去创建一个
T. Kumamoto | K. Takeda | T. Misumi | Yutaro Kikuchi | J. Watanabe | Y. Sawada | I. Endo | Chikara Kuniski
[1] T. Beppu,et al. Highly Advanced Colorectal Liver Metastases Successfully Treated With Fluorouracil Plus Leucovorin Monotherapy and Microwave Ablation , 2022, AntiCancer Research.
[2] T. Skalický,et al. Bevacizumab Does Not Inhibit the Formation of Liver Vessels and Liver Regeneration Following Major Hepatectomy: A Large Animal Model Study , 2022, In Vivo.
[3] J. Vauthey,et al. The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients , 2020, British Journal of Cancer.
[4] K. Hasegawa,et al. Impact of Surgical Resection on Metachronous Metastases of Colorectal Cancer According to Tumor Doubling Time , 2020, In Vivo.
[5] T. Skalický,et al. Long-term Results of Surgery for Colorectal Liver Metastases in Terms of Primary Tumour Location and Clinical Risk Factors , 2020, In Vivo.
[6] M. Sho,et al. Characteristics of Five-year Survivors After Liver Resection for Colorectal Liver Metastases in Modern Chemotherapy , 2020, AntiCancer Research.
[7] L. Holmberg,et al. Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon , 2019, Breast.
[8] C. Coenen. Invasive , 2019, Appalachian Heritage.
[9] G. Honda,et al. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases—a Japanese Nationwide Survey , 2019, Journal of Gastrointestinal Surgery.
[10] Matthew P. Goetz,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .
[11] K. Uchiyama,et al. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer? , 2018, Surgery Today.
[12] H. Baba,et al. The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases , 2018, International Journal of Clinical Oncology.
[13] B. Park,et al. Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates , 2017, Korean journal of radiology.
[14] Ahmed Kamel,et al. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[15] H. Sakamoto,et al. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. , 2017, Oncology reports.
[16] S. Kawasaki,et al. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial , 2016, PloS one.
[17] C. Punt,et al. Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection. , 2016, European journal of cancer.
[18] C. Verhoef,et al. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[19] G. Wakabayashi,et al. Proposal for novel histological findings of colorectal liver metastases with preoperative chemotherapy , 2015, Pathology international.
[20] H. Sorbye. Recurrence patterns after resection of liver metastases from colorectal cancer. , 2014, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[21] R. Parks,et al. Perioperative FOLFOX 4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC 40983 ) : long-term results of a randomised , controlled , phase 3 trial , 2013 .
[22] G. Honda,et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2012, Journal of hepato-biliary-pancreatic sciences.
[23] I. Endo,et al. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[24] C. Bokemeyer,et al. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] P. Tekkis,et al. Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer: A Multifactorial Model of 929 Patients , 2008, Annals of surgery.
[26] J. Bosset,et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] T. Pawlik,et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] I. Endo,et al. Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. , 2005, Surgery.
[29] D. Jäger,et al. [Systemic therapy for colorectal cancer]. , 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[30] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Daniel J Sargent,et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] L H Blumgart,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.
[33] A. Altendorf-Hofmann,et al. Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.